Abstract
Background: Zishen Tongguan (ZSTG) capsules were prepared at the Affiliated Hospital of Nanjing University of Chinese Medicine and have been proven to be clinically effective for treating pyelonephritis and benign prostatic hyperplasia. However, the quality standards are not ideal; a comprehensive study of the “quality markers” (Q-markers), the chemicals inherent in traditional Chinese medicine and its preparations, has not been carried out.
Experimental Methods: In this paper, a sensitive and specific ultra-high-performance liquid chromatographictandem mass spectrometry (UHPLC-MS/MS) method was developed for the simultaneous determination of eight potential Q-markers of ZSTG, including timosaponin A3, berberine, jatrorrhizine, phellodendrine, palmatine, mangiferin, neomangiferin, and timosaponin BII. A Kromasil 100-3.5 C18 column was used with a mobile phase of 0.2% formic acid with acetonitrile, and gradient elution at a flow rate of 0.2 mL/min was achieved in 13 minutes and used for separation. Detection was performed in positive/negative mode with multiple reaction monitoring (MRM).
Results: The analytical method was validated in terms of the sensitivity, linearity, accuracy, precision, repeatability, stability and recovery. The method established here was successfully applied to study the potential Q-markers in 8 batches of commercial samples, which demonstrated its use in improving the quality control of ZSTG.
Conclusion: The developed method had high repeatability and accuracy and was suitable for the simultaneous analysis of multiple Q-markers, which may provide a new basis for the comprehensive assessment and overall quality control of ZSTG.
Keywords: Zishen Tongguan Capsule, Q-Marker, Benign Prostatic Hyperplasia, Pyelonephritis, UHPLC–MS/MS, Quality Control.
Graphical Abstract
[1]
Bian, Q.; Wang, W.; Wang, N.; Peng, Y.; Ma, W.; Dai, R. Arachidonic acid metabolomic study of BPH in rats and the interventional effects of Zishen pill, a traditional Chinese medicine. J. Pharm. Biomed. Anal., 2016, 128, 149-157.
[http://dx.doi.org/10.1016/j.jpba.2016.05.027] [PMID: 27262108]
[http://dx.doi.org/10.1016/j.jpba.2016.05.027] [PMID: 27262108]
[2]
Dai, R.H.; Zhang, Y.Y.; Bi, K.S. [Study on the compatibility of composite herbal medicines of the Zishen pill] Zhongguo Zhongyao Zazhi, 2004, 29(9), 897-899.
[PMID: 15575214]
[PMID: 15575214]
[3]
Liu, C.X. Recognizing healthy development of Chinese medicine industry from resources-quality-quality markers of Chinese medicine. Chin. Tradit. Herbal Drugs, 2016, 47(18), 3149-3154.
[4]
Guo, D.A. Quality Marker Concept Inspires the Quality Research of Traditional Chinese Medicines. Chin. Herb. Med., 2017, 9(1), 1-2.
[http://dx.doi.org/10.1016/S1674-6384(17)60069-8]
[http://dx.doi.org/10.1016/S1674-6384(17)60069-8]
[5]
Liu, C.X.; Chen, S.L.; Xiao, X.H.; Zhang, T.J.; Hou, W.B.; Liao, M.L. A new concept on quality marker of Chinese materia medica: Quality control for Chinese medicinal products. Chin. Tradit. Herbal Drugs, 2016, 47(9), 1443-1457.
[6]
Yang, W.; Zhang, Y.; Wu, W.; Huang, L.; Guo, D.; Liu, C. Approaches to establish Q-markers for the quality standards of traditional Chinese medicines. Acta Pharm. Sin. B, 2017, 7(4), 439-446.
[http://dx.doi.org/10.1016/j.apsb.2017.04.012] [PMID: 28752028]
[http://dx.doi.org/10.1016/j.apsb.2017.04.012] [PMID: 28752028]
[7]
Liu, C.X.; Cheng, Y.Y.; Guo, D.A.; Zhang, T.J.; Li, Y.Z.; Hou, W.B.; Huang, L.Q. A new concept on quality marker for quality assessment and process control of chinese medicines. Chin. Herb. Med., 2017, 9(1), 3-13.
[http://dx.doi.org/10.1016/S1674-6384(17)60070-4]
[http://dx.doi.org/10.1016/S1674-6384(17)60070-4]
[8]
Xiang, W.; Suo, T.C.; Yu, H.; Li, A.P.; Zhang, S.Q.; Wang, C.H.; Zhu, Y.; Li, Z. A new strategy for choosing “Q-markers” via network pharmacology, application to the quality control of a Chinese medical preparation. Yao Wu Shi Pin Fen Xi, 2018, 26(2), 858-868.
[http://dx.doi.org/10.1016/j.jfda.2017.10.003] [PMID: 29567258]
[http://dx.doi.org/10.1016/j.jfda.2017.10.003] [PMID: 29567258]
[9]
Sun, H.; Li, T.J.; Sun, L.N.; Qiu, Y.; Huang, B.B.; Yi, B.; Chen, W.S. Inhibitory effect of traditional Chinese medicine Zi-Shen Pill on benign prostatic hyperplasia in rats. J. Ethnopharmacol., 2008, 115(2), 203-208.
[http://dx.doi.org/10.1016/j.jep.2007.09.026] [PMID: 18024035]
[http://dx.doi.org/10.1016/j.jep.2007.09.026] [PMID: 18024035]
[10]
Zhang, S.Q.; Zhou, C.C.; Cong, D.D.; Sui, S.G.; Liu, X.D. Treatment of prostatic hypertrophy with zhi bai kuncao tang (decoction of anemarrhena rhizome, phellodendron bark and motherwort). J. Tradit. Chin. Med., 1988, 8(4), 254-256.
[PMID: 2469909]
[PMID: 2469909]
[11]
Zhao, X.; Liu, C.; Qi, Y.; Fang, L.; Luo, J.; Bi, K.; Jia, Y. Timosaponin B-II ameliorates scopolamine-induced cognition deficits by attenuating acetylcholinesterase activity and brain oxidative damage in mice. Metab. Brain Dis., 2016, 31(6), 1455-1461.
[http://dx.doi.org/10.1007/s11011-016-9877-z] [PMID: 27444169]
[http://dx.doi.org/10.1007/s11011-016-9877-z] [PMID: 27444169]
[12]
Wang, M.; Yu, Y.; Brad, K.; Xie, W.; Zhang, X.Y. The screening and evaluation of herbs and identification of herbal combinations with anti-viral effects on Newcastle disease virus. Br. Poult. Sci., 2016, 57(1), 34-43.
[http://dx.doi.org/10.1080/00071668.2015.1119245] [PMID: 26927474]
[http://dx.doi.org/10.1080/00071668.2015.1119245] [PMID: 26927474]
[13]
Lim, S.M.; Jeong, J.J.; Choi, H.S.; Chang, H.B.; Kim, D.H. Mangiferin corrects the imbalance of Th17/Treg cells in mice with TNBS-induced colitis. Int. Immunopharmacol., 2016, 34, 220-228.
[http://dx.doi.org/10.1016/j.intimp.2016.03.004] [PMID: 26971225]
[http://dx.doi.org/10.1016/j.intimp.2016.03.004] [PMID: 26971225]
[14]
Jung, O.; Lee, J.; Lee, Y.J.; Yun, J.M.; Son, Y.J.; Cho, J.Y.; Ryou, C.; Lee, S.Y. Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways. Bioorg. Med. Chem. Lett., 2016, 26(16), 3963-3967.
[http://dx.doi.org/10.1016/j.bmcl.2016.07.004] [PMID: 27422337]
[http://dx.doi.org/10.1016/j.bmcl.2016.07.004] [PMID: 27422337]
[15]
Yang, B.Y.; Zhang, J.; Liu, Y.; Kuang, H.X. Steroidal Saponins from the Rhizomes of Anemarrhena asphodeloides. Molecules, 2016, 21(8), 1075.
[http://dx.doi.org/10.3390/molecules21081075] [PMID: 27548119]
[http://dx.doi.org/10.3390/molecules21081075] [PMID: 27548119]
[16]
Linn, Y.C.; Lu, J.; Lim, L.C.; Sun, H.; Sun, J.; Zhou, Y.; Ng, H.S. Berberine-induced haemolysis revisited: safety of Rhizoma coptidis and Cortex phellodendri in chronic haematological diseases. Phytother. Res., 2012, 26(5), 682-686.
[http://dx.doi.org/10.1002/ptr.3617] [PMID: 22002596]
[http://dx.doi.org/10.1002/ptr.3617] [PMID: 22002596]
[17]
Guo, K.J.; Xu, S.F.; Yin, P.; Wang, W.; Song, X.Z.; Liu, F.H.; Xu, J.Q.; Zoccarato, I. Active components of common traditional Chinese medicine decoctions have antioxidant functions. J. Anim. Sci., 2011, 89(10), 3107-3115.
[http://dx.doi.org/10.2527/jas.2010-3831] [PMID: 21571894]
[http://dx.doi.org/10.2527/jas.2010-3831] [PMID: 21571894]
[18]
Committee, N.P. Pharmacopoeia of People Republic of China, part 1; China Medical Science and Technology Press: Beijing, China, 2015.
[19]
Youn, D.H.; Park, J.; Kim, H.L.; Jung, Y.; Kang, J.; Lim, S.; Song, G.; Kwak, H.J.; Um, J.Y. berberine improves benign prostatic hyperplasia via suppression of 5 alpha reductase and extracellular signal-regulated kinase in Vivo and in Vitro. Front. Pharmacol., 2018, 9, 773.
[http://dx.doi.org/10.3389/fphar.2018.00773] [PMID: 30061836]
[http://dx.doi.org/10.3389/fphar.2018.00773] [PMID: 30061836]
[20]
Guh, J.H.; Hsieh, C.H.; Teng, C.M. Investigation of the effects of some alkaloidal alpha1-adrenoceptor antagonists on human hyperplastic prostate. Eur. J. Pharmacol., 1999, 374(3), 503-510.
[http://dx.doi.org/10.1016/S0014-2999(99)00352-0] [PMID: 10422796]
[http://dx.doi.org/10.1016/S0014-2999(99)00352-0] [PMID: 10422796]
[21]
Zhong, Y.M.; Chen, J.P.; Chen, S.L.; Feng, Y.F.; Zhong, X.L. Inhibitory functions of SAaB on LPS-induced RAW264.7 cells via NF-κB-iNOS-NO signaling pathway. Zhongguo Yaolixue Tongbao, 2019, 35, 198-202.
[22]
Guo, C.; Li, L.; Yang, X.; Meng, Z.; Li, F.; Zhang, C.; Yang, Z. Protective effects of timosaponin B-II on high glucose-induced apoptosis in human umbilical vein endothelial cells. Environ. Toxicol. Pharmacol., 2014, 37(1), 37-44.
[http://dx.doi.org/10.1016/j.etap.2013.11.009] [PMID: 24295731]
[http://dx.doi.org/10.1016/j.etap.2013.11.009] [PMID: 24295731]
[23]
Mehta, P.; Dhapte, V. A Comprehensive Review on Pharmacokinetic Profile of Some Traditional Chinese Medicines. New J. Sci.,, 2016. 7830367
[http://dx.doi.org/10.1155/2016/7830367]
[http://dx.doi.org/10.1155/2016/7830367]
[24]
Liang, C.L.; Lu, W.; Zhou, J.Y.; Chen, Y.; Zhang, Q.; Liu, H.; Qiu, F.; Dai, Z. Mangiferin Attenuates Murine Lupus Nephritis by Inducing CD4+Foxp3+ Regulatory T Cells via Suppression of mTOR Signaling. Cell. Physiol. Biochem., 2018, 50(4), 1560-1573.
[http://dx.doi.org/10.1159/000494654] [PMID: 30359968]
[http://dx.doi.org/10.1159/000494654] [PMID: 30359968]
[25]
Sahu, A.K.; Verma, V.K.; Mutneja, E.; Malik, S.; Nag, T.C.; Dinda, A.K.; Arya, D.S.; Bhatia, J. Mangiferin attenuates cisplatin-induced acute kidney injury in rats mediating modulation of MAPK pathway. Mol. Cell. Biochem., 2019, 452(1-2), 141-152.
[http://dx.doi.org/10.1007/s11010-018-3420-y] [PMID: 30083783]
[http://dx.doi.org/10.1007/s11010-018-3420-y] [PMID: 30083783]
[26]
Li, J.; Chen, L.; Wu, H.; Lu, Y.; Hu, Z.; Lu, B.; Zhang, L.; Chai, Y.; Zhang, J. The Mixture of Salvianolic Acids from Salvia miltiorrhiza and Total Flavonoids from Anemarrhena asphodeloides Attenuate Sulfur Mustard-Induced Injury. Int. J. Mol. Sci., 2015, 16(10), 24555-24573.
[http://dx.doi.org/10.3390/ijms161024555] [PMID: 26501264]
[http://dx.doi.org/10.3390/ijms161024555] [PMID: 26501264]
[27]
Henc, I.; Kokotkiewicz, A.; Łuczkiewicz, P.; Bryl, E.; Łuczkiewicz, M.; Witkowski, J.M. Naturally occurring xanthone and benzophenone derivatives exert significant anti-proliferative and proapoptotic effects in vitro on synovial fibroblasts and macrophages from rheumatoid arthritis patients. Int. Immunopharmacol., 2017, 49, 148-154.
[http://dx.doi.org/10.1016/j.intimp.2017.05.034] [PMID: 28587985]
[http://dx.doi.org/10.1016/j.intimp.2017.05.034] [PMID: 28587985]
[28]
Tan, H.Y.; Wang, N.; Tsao, S.W.; Zhang, Z.; Feng, Y. Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma. Integr. Cancer Ther., 2014, 13(5), 425-434.
[http://dx.doi.org/10.1177/1534735413513635] [PMID: 24363282]
[http://dx.doi.org/10.1177/1534735413513635] [PMID: 24363282]
[29]
Yan, B.; Wang, D.; Dong, S.; Cheng, Z.; Na, L.; Sang, M.; Yang, H.; Yang, Z.; Zhang, S.; Yan, Z. Palmatine inhibits TRIF-dependent NF-κB pathway against inflammation induced by LPS in goat endometrial epithelial cells. Int. Immunopharmacol., 2017, 45, 194-200.
[http://dx.doi.org/10.1016/j.intimp.2017.02.004] [PMID: 28236763]
[http://dx.doi.org/10.1016/j.intimp.2017.02.004] [PMID: 28236763]
[30]
Zeng, H.; Dou, S.; Zhao, J.; Fan, S.; Yuan, X.; Zhu, S.; Li, L.; Zhang, W.; Liu, R. The inhibitory activities of the components of Huang-Lian-Jie-Du-Tang (HLJDT) on eicosanoid generation via lipoxygenase pathway. J. Ethnopharmacol., 2011, 135(2), 561-568.
[http://dx.doi.org/10.1016/j.jep.2011.03.055] [PMID: 21466840]
[http://dx.doi.org/10.1016/j.jep.2011.03.055] [PMID: 21466840]
[31]
Su, X.N.; Ji, D.; Zhou, Y.P.; Wang, L.J.; Zang, W.Y.; Mao, C.Q.; Lu, T.L. [Simultaneous determination of flavones and saponins of Rhizoma Anemarrhenae by HPLC-DAD-ELSD] Zhongguo Zhongyao Zazhi, 2015, 40(1), 108-111.
[PMID: 25993798]
[PMID: 25993798]
[32]
Zhang, F.; Yang, Q.; Sun, L.N.; Gao, S.H.; Tao, X.; Chen, W.S. Fingerprint analysis of Zhimu-Huangbai herb pair and simultaneous determination of its alkaloids, xanthone glycosides and steroidal saponins by HPLC-DAD-ELSD. Chin. J. Nat. Med., 2014, 12(7), 525-534.
[http://dx.doi.org/10.1016/S1875-5364(14)60082-0] [PMID: 25053552]
[http://dx.doi.org/10.1016/S1875-5364(14)60082-0] [PMID: 25053552]
[33]
Zhang, Z.; Zhang, Y.; Zhang, Z.; Yao, H.; Liu, H.; Zhang, B.; Liao, Y. Comparative analysis of DNA barcoding and HPLC fingerprint to trace species of Phellodendri Cortex, an important traditional chinese medicine from multiple sources. Biol. Pharm. Bull., 2016, 39(8), 1325-1330.
[http://dx.doi.org/10.1248/bpb.b16-00210] [PMID: 27298183]
[http://dx.doi.org/10.1248/bpb.b16-00210] [PMID: 27298183]
[34]
Liu, D.S.; Xiong, X.J.; Wu, Z.J.; Piao, S.J.; Lu, W.Q. Study on Quality Standard for Zishen Tongguan Capsules. Zhongguo Zhongyiyao Xinxi Zazhi, 2016, 23(7), 104-107.
[35]
US Food and Drug Administration. Guidance for industry, bioanalytical method validation. US2001
[36]
Wu, X.; Zhou, Y.; Yin, F.; Mao, C.; Li, L.; Cai, B.; Lu, T. Quality control and producing areas differentiation of Gardeniae Fructus for eight bioactive constituents by HPLC-DAD-ESI/MS. Phytomedicine, 2014, 21(4), 551-559.
[http://dx.doi.org/10.1016/j.phymed.2013.10.002] [PMID: 24183952]
[http://dx.doi.org/10.1016/j.phymed.2013.10.002] [PMID: 24183952]
[37]
Wang, Y.; Liao, D.; Qin, M.; Li, X. simultaneous determination of catalpol, aucubin, and geniposidic acid in different developmental stages of rehmannia glutinosa leaves by high performance liquid chromatography. J. Anal. Methods Chem., 2016.20164956589
[http://dx.doi.org/10.1155/2016/4956589] [PMID: 27429834]
[http://dx.doi.org/10.1155/2016/4956589] [PMID: 27429834]
[38]
Zhao, Y.; Yu, Z.; Fan, R.; Gao, X.; Yu, M.; Li, H.; Wei, H.; Bi, K. Simultaneous determination of ten flavonoids from Viscum coloratum grown on different host species and different sources by LC-MS. Chem. Pharm. Bull. (Tokyo), 2011, 59(11), 1322-1328.
[http://dx.doi.org/10.1248/cpb.59.1322] [PMID: 22041066]
[http://dx.doi.org/10.1248/cpb.59.1322] [PMID: 22041066]
[39]
Zhang, H.Q.; Liu, P.; Duan, J.A.; Dong, L.; Shang, E.X.; Qian, D.W.; Xiao, P.; Zhao, M.; Li, W.W. Hierarchical extraction and simultaneous determination of flavones and triterpenes in different parts of Trichosanthes kirilowii Maxim. by ultra-high-performance liquid chromatography coupled with tandem mass spectrometry. J. Pharm. Biomed. Anal., 2019, 167, 114-122.
[http://dx.doi.org/10.1016/j.jpba.2019.02.003] [PMID: 30763882]
[http://dx.doi.org/10.1016/j.jpba.2019.02.003] [PMID: 30763882]
Article Metrics
13